The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • COASTER1921@lemmy.ml
    6·
    12 hours ago

    The sad part is that some people have unwillingly had their DNA shared. My parents both did it without me knowing so now they already have my information too.

    • Bloomcole@lemmy.world
      41·
      11 hours ago

      Indeed, the way it works is horribly effective and invades the privacy of an entire bloodline.